785960005: Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug)

• SNOMED CT Concept\produit pharmaceutique ou biologique\Medicinal product (product)\...
• \Product manufactured as oromucosal dose form (product)\Carbidopa- and levodopa-containing product in oromucosal dose form\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Medicinal product categorized by disposition (product)\inhibiteur enzymatique\Product containing dihydroxyphenylalanine decarboxylase inhibitor (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Carbidopa- and levodopa-containing product in oromucosal dose form\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Medicinal product categorized by disposition (product)\inhibiteur enzymatique\Product containing dihydroxyphenylalanine decarboxylase inhibitor (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Carbidopa- and levodopa-containing product in oromucosal dose form\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Carbidopa- and levodopa-containing product in oromucosal dose form\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Medicinal product categorized by disposition (product)\Product containing dopamine receptor agonist (product)\Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Medicinal product categorized by structure\Nitrogen and/or nitrogen compound-containing product\Product containing catecholamine (product)\...
• \Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\...
• \Carbidopa- and levodopa-containing product in oromucosal dose form\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Product containing only carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\...
• \Carbidopa- and levodopa-containing product in oromucosal dose form\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Product containing only carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Medicinal product categorised by therapeutic role\Antiparkinson agent\...
• \Product containing carbidopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\...
• \Carbidopa- and levodopa-containing product in oromucosal dose form\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Product containing only carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Product containing levodopa (medicinal product)\Product containing carbidopa and levodopa (medicinal product)\...
• \Carbidopa- and levodopa-containing product in oromucosal dose form\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet
• \Product containing only carbidopa and levodopa (medicinal product)\Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form)\Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
3769839012	Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3769840014	Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start